Ethio-Norwegian Hepatology Consortium

Towards a future without viral hepatitis

A Growing Public Health Concern

Hepatitis B in Ethiopia

Hepatitis B is a significant public health issue in Ethiopia, affecting millions and posing serious health risks. Despite efforts to control the disease, widespread transmission continues due to limited awareness, inadequate vaccination coverage, and insufficient healthcare infrastructure. Increasing public education, improving vaccination rates, and strengthening healthcare systems are critical steps needed to combat Hepatitis B and safeguard the health of the Ethiopian population.

About Us

EtNoHep was formalized as an NGO in 2024, but its history started already a decade before when Ethiopian and Norwegian researchers came together to establish a pilot program for treatment of hepatitis B at St. Paul’s Hospital in Addis Ababa. Simultaneously, the group was intrigued by the high prevalence of unexplained liver disease in eastern Ethiopia, and set up a case-control study aiming to reveal the underlying causes.

Since then, multiple other research projects have been added to the portfolio, mainly focused on hepatitis B. We have enrolled more than 7000 people living with hepatitis B in different research projects, and more than 2000 have received antiviral treatment through our programs. The projects have attracted international funders such as the South-Eastern Norwegian Health Authority, the Norwegian Research Council, Gavi and John C. Martin Foundation.

Get Started

Welcome to Ethio-Norwegian Hepatology Consortium

Ethiopian and Norwegian researchers program for treatment of hepatitis B at St. Paul’s Hospital in Addis Ababa.

Since then, multiple other research projects have been added to the portfolio, mainly focused on hepatitis B. We have enrolled more than 7000 people living with hepatitis B in different research projects, and more than 2000 have received antiviral treatment through our programs. The projects have attracted international funders such as the South-Eastern Norwegian Health Authority, the Norwegian Research Council, Gavi and John C. Martin Foundation.

Get Started